HKD 1.1
(-1.79%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -386.04 Million CNY | -8.17% |
2022 | -347.91 Million CNY | -86.17% |
2021 | -126.43 Million CNY | 22.29% |
2020 | -227.43 Million CNY | -49.76% |
2019 | -118.33 Million CNY | -92.1% |
2018 | -56.55 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q4 | -110.24 Million CNY | 0.0% |
2023 Q1 | -78.4 Million CNY | 35.48% |
2023 Q2 | -78.4 Million CNY | 0.0% |
2023 Q3 | -110.24 Million CNY | -40.61% |
2023 FY | - CNY | -8.17% |
2022 Q1 | -47.2 Million CNY | 18.77% |
2022 Q4 | -121.51 Million CNY | -1.46% |
2022 Q3 | -119.76 Million CNY | -153.74% |
2022 FY | - CNY | -86.17% |
2022 Q2 | -47.2 Million CNY | 0.0% |
2021 FY | - CNY | 22.29% |
2021 Q4 | -58.1 Million CNY | -2.14% |
2021 Q2 | -25.23 Million CNY | 0.0% |
2021 Q3 | -56.88 Million CNY | -125.43% |
2021 Q1 | -25.23 Million CNY | 74.48% |
2020 Q2 | -25.24 Million CNY | 0.0% |
2020 Q1 | -25.24 Million CNY | 0.0% |
2020 Q3 | -99.55 Million CNY | -294.35% |
2020 FY | - CNY | -49.76% |
2020 Q4 | -98.89 Million CNY | 0.66% |
2019 FY | - CNY | -92.1% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Vincent Medical Holdings Limited | 104.43 Million HKD | 469.665% |